Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Public Advisory - Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario


OTTAWA, ON, Sept. 6, 2022 /CNW/ - 

Summary

Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario (CNW Group/Health Canada)

Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario (CNW Group/Health Canada)

Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario (CNW Group/Health Canada)

Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario (CNW Group/Health Canada)

Counterfeit Nuceiva injectable drug seized from New You Spa in Vaughan, Ontario (CNW Group/Health Canada)

Affected products

Product

Strength

DIN

Lot

Expiry date

Counterfeit Nuceiva (Prabotulinumtoxin A) for injection

100 units/vial

02480158

121661

2023-04

Issue

Health Canada inspectors seized counterfeit Nuceiva (Prabotulinumtoxin A) from a New You Spa location in Vaughan, Ontario (Unit 5, 60 Winges Road). Nuceiva is botulinum toxin type A prescription drug that is administered by injection for the temporary improvement of facial wrinkling in adults 18 years of age and older.

Health Canada has confirmed with Evolus Inc., the manufacturer of Nuceiva, that the seized products are counterfeit. The counterfeit Nuceiva is labelled with lot 121661 and expiry 2023-04. Evolus Inc. confirmed there is an authorized lot with the same number; the lot expired in 2022-04. In addition, Evolus Inc. confirmed that:

Counterfeit drugs are made to look like authentic products, but they may not be the same and they can pose serious health risks. For example, they could contain a higher dosage than shown on the label, contaminants or hidden dangerous ingredients that can seriously harm your health. On the other hand, they might not contain the drug at all. Unlike authorized and authentic drug products, counterfeit drugs have not been assessed by Health Canada for safety, effectiveness and quality. Selling counterfeit health products in Canada is illegal.

Botulinum toxin type A is used for cosmetic purposes to treat facial wrinkling. Some products containing botulinum toxin type A are also used to treat severe muscle spasms in the neck, eye and foot, as well as chronic migraines, urinary incontinence, and excessive sweating. Authorized botulinum toxin type A products should only be used under specialist supervision and only if the benefits of treatment are considered to outweigh the risks. Potential risks associated with injecting an unauthorized Botulinum toxin type A product can range from mild local paralysis to death. In addition, unauthorized injectable health products for cosmetic purposes carry significant risk because of the potential for infection, scarring and poor outcomes. All products administered by injection in Canada must be authorized for sale by Health Canada.

Également disponible en français

SOURCE Health Canada


These press releases may also interest you

at 04:00
May 17, 2024 Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs Amsterdam, the Netherlands...

at 04:00
Brainomix, a pioneer in artificial intelligence (AI) imaging solutions to enable precision medicine, is proud to announce the FDA clearance of...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announced its presence at Heart Rhythm 2024, the Annual Meeting of the Heart Rhythm Society (HRS) in the U.S. At Heart Rhythm 2024, the Company will showcase its upper-arm blood...

at 03:00
Hypertension, or high blood pressure, affects one in three Europeans over the age of 30 and more than one billion people worldwide.  Hypertension is known as the "silent killer" because many people do not know they have it and, over time, it can lead...

at 03:00
At the Summit on Clean Cooking in Africa, World Resources Institute (WRI) and the Clean Cooking Alliance (CCA) announced a strategic partnership to further embed clean cooking into a broad range of sustainable development initiatives across the two...

at 02:00
QuTEM AB (formerly Vironova BioAnalytics AB), a leading provider of transmission electron microscopy (TEM) services, proudly announces the receipt of GMP (Good Manufacturing Practice) Certificates and Manufacturing Permits for Independent Quality...



News published on and distributed by: